5 August 2025
Livers | Issue Cover Collection Published in 2023

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
![]() |
1. “Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment” by Jeffrey Wu, Bradley Maller, Rujul Kaul, Andrea Galabow, Allyn Bryan and Alexander Neuwelt Livers 2024, 4(1), 84-93; https://doi.org/10.3390/livers4010007 Available online: https://www.mdpi.com/2661142 |
![]() |
2. “Peritoneal Immunity in Liver Disease” by Joseph Delo, Daniel Forton, Evangelos Triantafyllou and Arjuna Singanayagam Livers 2023, 3(2), 240-257; https://doi.org/10.3390/livers3020016 Available online: https://www.mdpi.com/2266224 |
![]() |
3. “Challenges in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD): Towards a Compassionate Approach” by Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Lukasz Lagojda, Surinderjeet S. Chaggar, Ioannis Kyrou and Harpal S. Randeva Livers 2023, 3(3), 434-447; https://doi.org/10.3390/livers3030031 Available online: https://www.mdpi.com/2449440 |
![]() |
4. “The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review” by Mitchell R. McGill and Steven C. Curry Livers 2023, 3(4), 569-596; https://doi.org/10.3390/livers3040039 Available online: https://www.mdpi.com/2536894 |